Suche
Mein Konto
Revolution in resuscitation: St. Wendel introduces AutoPulse NXT!
Marienhaus Klinikum St. Wendel implements AutoPulse® NXT for effective resuscitation, significantly improving patient care.
Revolution in resuscitation: St. Wendel introduces AutoPulse NXT!
The Marienhaus Klinikum St. Wendel-Ottweiler sets new standards in emergency medicine. Today it was announced that the clinic is the first facility in Germany to use ZOLL Medical Corporation's innovative AutoPulse® NXT resuscitation solution. This state-of-the-art device revolutionizes resuscitation technology and promises significant improvements in patient care.
The introduction of AutoPulse NXT will take place in the hospital's newly opened cardiac catheter laboratory. The technology enables automatic, consistent and efficient chest compressions for patients suffering from cardiac arrest. Unlike traditional punch-driven mechanical resuscitation devices, AutoPulse NXT uses mechanical band compression, placing a band around the patient's torso that automatically adjusts to the chest circumference.
Benefits of AutoPulse NXT technology
Dr. Tayfun Kaplan, chief physician of cardiology, highlights the benefits of constant chest compressions, which can be carried out regardless of the physical exhaustion of the medical staff. This continuous compression improves blood supply to the heart and brain during resuscitation and is particularly beneficial in situations where a longer period of resuscitation or patient transport is required.
The medical staff therefore has the opportunity to concentrate on further life-sustaining measures during use, which significantly increases the efficiency of emergency treatment. This not only improves the working conditions of the staff, but also the patients' chances of survival.
Proven clinical benefits
AutoPulse NXT technology offers proven clinical benefits. The results show that the circumferential compression of the device significantly improves blood flow. According to data from the CIRC study, return of spontaneous circulation (ROSC) rates were increased by a remarkable 62 percent compared to manual resuscitation. Additionally, 60 percent of patients survived in-hospital cardiac arrest when AutoPulse NXT was combined with ECMO (extracorporeal membrane oxygenation) and therapeutic hypothermia.
The introduction of the AutoPulse NXT is considered an important step in patient care in the St. Wendel district and represents an advance that not only improves treatment outcomes, but also significantly reduces the risk of 30-day mortality, compared to other mechanical resuscitation devices that work on the stamp principle.
With this change in technology, the Marienhaus Klinikum St. Wendel-Ottweiler is positioning itself as a pioneer in the field of modern medical technology and is making a decisive contribution to improving patient care in emergency management. Further information about the innovative practice can be found at wochenspiegelonline.de and habel-medizintechnik.at.